These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25754767)

  • 1. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
    Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
    Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
    Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
    Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
    Yunoki T; Tabuchi Y; Hayashi A; Kondo T
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8353-63. PubMed ID: 24366665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
    Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
    Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
    Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
    Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
    Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
    Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
    Iida M; Matsuda M; Komatani H
    Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastoma.
    Singh L; Saini N; Pushker N; Sen S; Sharma A; Kashyap S
    Int J Clin Oncol; 2016 Aug; 21(4):651-657. PubMed ID: 26857459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
    Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
    Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
    Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
    Ma H; Nie C; Chen Y; Li J; Xie Y; Tang Z; Gao Y; Ai S; Mao Y; Sun Q; Lu R
    Oncol Res; 2021 Sep; 28(7):745-761. PubMed ID: 33573708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery.
    Strebhardt K; Becker S; Matthess Y
    Expert Opin Drug Discov; 2015 Jan; 10(1):1-8. PubMed ID: 25263688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
    Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Cebrián A; Gómez Del Pulgar T; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Manzarbeitia F; García-Foncillas J
    Pathol Res Pract; 2016 Dec; 212(12):1133-1137. PubMed ID: 27712975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer.
    Tut TG; Lim SH; Dissanayake IU; Descallar J; Chua W; Ng W; de Souza P; Shin JS; Lee CS
    PLoS One; 2015; 10(6):e0129313. PubMed ID: 26047016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
    Liu L; Zhang M; Zou P
    Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Plk3 in oncogenesis.
    Helmke C; Becker S; Strebhardt K
    Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.
    Zhang G; Zhang Z; Liu Z
    Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.